Evaluating possible maternal effect lethality of Naa10 knockout mice, and modulation of phenotypes for embryonic and neonatal lethality by genetic background and environment

Amino-terminal (Nt-) acetylation (NTA) is a common protein modification, affecting approximately 80% of all human proteins. The human essential X-linked gene, NAA10, encodes for the enzyme NAA10, which is the catalytic subunit in the N-terminal acetyltransferase A (NatA) complex, also including the accessory protein, NAA15, encoded by the autosomal gene, NAA15. Although NAA10 is an essential gene in humans, there is nonetheless extensive genetic variation in humans with missense, splice-site, and C-terminal frameshift variants in NAA10. Likewise, the genetic spectrum for NAA15 is also extensive, where the mechanism likely involves haploinsufficiency in heterozygous individuals. The phenotypic presentation in humans with NAA10 or NAA15 variants includes variable levels of intellectual disability, delayed milestones, autism spectrum disorder, craniofacial dysmorphology, cardiac anomalies, seizures, and visual abnormalities. In mice, Naa10 is not an essential gene, as there exists a paralogous gene, Naa12, that substantially rescues Naa10 knockout mice from embryonic lethality, whereas double knockouts (Naa10-/Y Naa12-/-) are embryonic lethal. However, the phenotypic variability in the mice is nonetheless quite extensive, including piebaldism, skeletal defects, small size, hydrocephaly, hydronephrosis, and neonatal lethality. Here we show that the mouse phenotypes are replicated with new genetic alleles, but are modulated by genetic background and environmental effects, as demonstrated by several new mouse strains and backcrossing of the original Naa10 null allele 20 generations to inbred C57BL/6J mice in a different animal facility. We cannot replicate a prior report of "maternal effect lethality" for heterozygous Naa10-/X female mice, but we do observe a small amount of embryonic lethality in the Naa10-/y male mice on the inbred genetic background in this different animal facility. We hypothesize that decreased NTA of many different target substrate proteins is the main explanation for the variable phenotypic outcomes, and future experiments will make use of these mice and human cell lines to address this hypothesis.

[1]  G. Lyon,et al.  Phenotypic variability and gastrointestinal manifestations/interventions for growth in NAA10‐related neurodevelopmental syndrome , 2023, American journal of medical genetics. Part A.

[2]  A. Jezela-Stanek,et al.  Case report: Rare among ultrarare—Clinical odyssey of a new patient with Ogden syndrome , 2022, Frontiers in Genetics.

[3]  Quan,et al.  Expanding the Phenotypic spectrum of Ogden syndrome (NAA10-related neurodevelopmental syndrome) and NAA15-related neurodevelopmental syndrome , 2022, medRxiv.

[4]  Lung-Chuang Wang,et al.  Possible Catch-Up Developmental Trajectories for Children with Mild Developmental Delay Caused by NAA15 Pathogenic Variants , 2022, Genes.

[5]  Z. Tümer,et al.  Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation , 2022, Human Genetics.

[6]  L. Garavelli,et al.  Clinical Manifestations in a Girl with NAA10-Related Syndrome and Genotype–Phenotype Correlation in Females , 2021, Genes.

[7]  B. Tutschek,et al.  Confirmation of Ogden syndrome as an X‐linked recessive fatal disorder due to a recurrent NAA10 variant and review of the literature , 2021, American journal of medical genetics. Part A.

[8]  Craig C. Benson,et al.  Mechanisms of Congenital Heart Disease Caused by NAA15 Haploinsufficiency , 2021, Circulation research.

[9]  Tae-Young Roh,et al.  Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway , 2020, bioRxiv.

[10]  S. Rajasekaran,et al.  NAA10 variant in 38-week-gestation male patient: a case study , 2020, Cold Spring Harbor molecular case studies.

[11]  L. Medne,et al.  Variants in NAA15 cause pediatric hypertrophic cardiomyopathy , 2020, American journal of medical genetics. Part A.

[12]  T. Arnesen,et al.  NAA10 p.(N101K) disrupts N-terminal acetyltransferase complex NatA and is associated with developmental delay and hemihypertrophy , 2020, European Journal of Human Genetics.

[13]  T. Arnesen,et al.  Severe syndromic ID and skewed X-inactivation in a girl with NAA10 dysfunction and a novel heterozygous de novo NAA10 p.(His16Pro) variant - a case report , 2020, BMC Medical Genetics.

[14]  D. Baralle,et al.  Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15. , 2020, Human molecular genetics.

[15]  L. Juan,et al.  Naa10p Inhibits Beige Adipocyte-Mediated Thermogenesis through N-α-acetylation of Pgc1α. , 2019, Molecular cell.

[16]  T. Arnesen,et al.  A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly , 2019, BMC Medical Genetics.

[17]  D. Baralle,et al.  Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15. , 2019, Human molecular genetics.

[18]  N. Couser,et al.  Ocular Manifestations of the NAA10-Related Syndrome , 2019, Case reports in genetics.

[19]  Jeffrey N. Dudley,et al.  NAA10 polyadenylation signal variants cause syndromic microphthalmia , 2019, Journal of Medical Genetics.

[20]  T. Arnesen,et al.  Co-translational, Post-translational, and Non-catalytic Roles of N-Terminal Acetyltransferases. , 2019, Molecular cell.

[21]  Jie Zhao,et al.  N&agr;-Acetyltransferases 10 and 15 are Required for the Correct Initiation of Endosperm Cellularization in Arabidopsis , 2018, Plant & cell physiology.

[22]  T. Arnesen,et al.  Spotlight on protein N-terminal acetylation , 2018, Experimental & Molecular Medicine.

[23]  R. Marmorstein,et al.  Structure of Human NatA and Its Regulation by the Huntingtin Interacting Protein HYPK. , 2018, Structure.

[24]  J. Lupski,et al.  A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy , 2018, European Journal of Human Genetics.

[25]  J. Rosenfeld,et al.  Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies. , 2018, American journal of human genetics.

[26]  Ligeng Ma,et al.  Protein N-terminal acetylation is required for embryogenesis in Arabidopsis , 2016, Journal of experimental botany.

[27]  J. Swinnen,et al.  CRISP-ID: decoding CRISPR mediated indels by Sanger sequencing , 2016, Scientific Reports.

[28]  T. Arnesen,et al.  Expanding the Phenotype Associated with NAA10‐Related N‐Terminal Acetylation Deficiency , 2016, Human mutation.

[29]  G. Lyon,et al.  Proteomic and genomic characterization of a yeast model for Ogden syndrome , 2016, bioRxiv.

[30]  S. Conway,et al.  Restricted Pax3 Deletion within the Neural Tube Results in Congenital Hydrocephalus , 2016, Journal of developmental biology.

[31]  R. Marmorstein,et al.  The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues* , 2016, The Journal of Biological Chemistry.

[32]  G. Superti-Furga,et al.  Gene essentiality and synthetic lethality in haploid human cells , 2015, Science.

[33]  J. Casey,et al.  NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment , 2015, Scientific Reports.

[34]  E. Lander,et al.  Identification and characterization of essential genes in the human genome , 2015, Science.

[35]  G. Lyon,et al.  The biological functions of Naa10 - From amino-terminal acetylation to human disease. , 2015, Gene.

[36]  M. Reichelt,et al.  Downregulation of N-terminal acetylation triggers ABA-mediated drought responses in Arabidopsis , 2015, Nature Communications.

[37]  N. Reuter,et al.  Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects , 2014, Human molecular genetics.

[38]  T. Arnesen,et al.  De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females , 2014, European Journal of Human Genetics.

[39]  Dong Yeon Lee,et al.  NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2 , 2014, Nature Communications.

[40]  D. Riddle,et al.  daf-31 Encodes the Catalytic Subunit of N Alpha-Acetyltransferase that Regulates Caenorhabditis elegans Development, Metabolism and Adult Lifespan , 2014, PLoS genetics.

[41]  R. Gutenkunst,et al.  Loss of N-terminal Acetylation Suppresses A Prion Phenotype By Modulating Global Protein Folding , 2014, Nature Communications.

[42]  Jason O'Rawe,et al.  Human genetics and clinical aspects of neurodevelopmental disorders , 2014, bioRxiv.

[43]  R. Chadwick,et al.  A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome , 2014, Journal of Medical Genetics.

[44]  T. Arnesen,et al.  A Saccharomyces cerevisiae Model Reveals In Vivo Functional Impairment of the Ogden Syndrome N-Terminal Acetyltransferase NAA10 Ser37Pro Mutant* , 2014, Molecular & Cellular Proteomics.

[45]  D. Eliezer,et al.  N-terminal Acetylation Stabilizes N-terminal Helicity in Lipid- and Micelle-bound α-Synuclein and Increases Its Affinity for Physiological Membranes* , 2013, The Journal of Biological Chemistry.

[46]  A. Varshavsky,et al.  Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway. , 2013, Molecular cell.

[47]  Kris Gevaert,et al.  Protein N-terminal acetyltransferases: when the start matters. , 2012, Trends in biochemical sciences.

[48]  J. Harper,et al.  N-Terminal Acetylation Acts as an Avidity Enhancer Within an Interconnected Multiprotein Complex , 2011, Science.

[49]  O. Rennert,et al.  Expression of human NAA11 (ARD1B) gene is tissue-specific and is regulated by DNA methylation , 2011, Epigenetics.

[50]  G. Lyon.  Personal account of the discovery of a new disease using next-generation sequencing. Interview by Natalie Harrison. , 2011, Pharmacogenomics.

[51]  R. Schwartz,et al.  Pax3 is essential for normal cardiac neural crest morphogenesis but is not required during migration nor outflow tract septation. , 2011, Developmental biology.

[52]  H. Hakonarson,et al.  Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency. , 2011, American journal of human genetics.

[53]  Kevin I Manage,et al.  Drosophila variable nurse cells encodes arrest defective 1 (ARD1), the catalytic subunit of the major N‐terminal acetyltransferase complex , 2010, Developmental dynamics : an official publication of the American Association of Anatomists.

[54]  H. Dinh,et al.  The Chaperone-Like Protein HYPK Acts Together with NatA in Cotranslational N-Terminal Acetylation and Prevention of Huntingtin Aggregation , 2010, Molecular and Cellular Biology.

[55]  T. Arnesen,et al.  A synopsis of eukaryotic Nα-terminal acetyltransferases: nomenclature, subunits and substrates , 2009, BMC proceedings.

[56]  R. Evjenth,et al.  Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans , 2009, Proceedings of the National Academy of Sciences.

[57]  D. Liberles,et al.  Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-α-acetyltransferase , 2006, BMC Biochemistry.

[58]  M. Lanotte,et al.  Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. , 2005, The Biochemical journal.

[59]  J. Durocher,et al.  Mutation detection using Surveyor nuclease. , 2004, BioTechniques.

[60]  A. Moorman,et al.  Cardiac neural crest: the holy grail of cardiac abnormalities? , 2000, Cardiovascular research.

[61]  S. Conway,et al.  Abnormal skeletogenesis occurs coincident with increased apoptosis in the Splotch (Sp2H) mutant: Putative roles for Pax3 and PDGFRα in rib patterning , 1999, The Anatomical record.

[62]  A. Copp,et al.  Rib truncations and fusions in the Sp2H mouse reveal a role for Pax3 in specification of the ventro-lateral and posterior parts of the somite. , 1999, Developmental biology.

[63]  A. Copp,et al.  Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse. , 1997, Cardiovascular research.

[64]  A. Copp,et al.  Pax3 is required for cardiac neural crest migration in the mouse: evidence from the splotch (Sp2H) mutant. , 1997, Development.

[65]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .

[66]  Susumu,et al.  Identification and characterization of genes and mutants for an N‐terminal acetyltransferase from yeast. , 1989, The EMBO journal.

[67]  Yi,et al.  The Role of N-alpha-acetyltransferase 10 Protein in DNA Methylation and Genomic Imprinting , 2022 .